Ablative treatment of thyroid cancer with high doses of i without pre-therapy scanning

Nuclear Medicine Communications

Volumn 26, Issue 2, 2005, Pages 129-132

  Rosário, Pedro W S ^a   Barroso, Álvaro L ^a   Rezende, Leonardo L ^a   Padrão, Eduardo L ^a   Borges, Michelle A R ^a   Fagundes, Tales A ^a   Purisch, Saulo ^a  

^a Endocrinology Service   (Brazil)

Author keywords

Ablative treatment; Thyroid cancer

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; DRUG EFFICACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; RETROSPECTIVE STUDY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

ADULT; BRAZIL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 13944273456     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200502000-00008     Document Type: Article

References (21)

1. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414-424.
2. Mazzaferri EL, Kloos R. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:1447-1463.
3. Schlumberger MJ. Medical progress - papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338:297-306.
4. Dorn R, Kopp J, Vogt H, Heidenreich P, Carroll RG, Gulec SA. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach. J Nucl Med 2003; 44:451-456.
5. Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992; 33:1132-1136.
6. 131I dose in differentiated thyroid cancer. Clin Endocrinol 2000; 52:765-773.
7. Gawkowska-Suwinska M, Turska M, Roskosz J, Puch Z, Jurecka-Tuleja B, Handkiewicz-Junak D, et al. Early evaluation of treatment effectiveness using iodine-131 radiotherapy in patients with differentiated thyroid cancer. Wiad Lek 2001; 54:278-288.
8. Hodgson DC, Brierly JD, Tsang RW, Panzarella T. Prescribing iodine-131 based on neck uptake produces effective thyroid ablation and reduces hospital stay. Radiother Oncol 1998; 47:325-330.
9. Beierwaltes WH, Rabbani R, Dmuchowski C, Lloyd RV, Eyre P, Mallette S. An analysis of ‘ablation of thyroid remnants’ with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med 1984; 25:1287-1293.
10. 131I scintigraphy. Nucl Med Commun 2000; 21:529-532.
11. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid carcinoma? J Clin Endocrinol Metab 2000; 85:175-178.
12. 131I in patients with differentiated thyroid carcinoma. Nucl Med Commun 2001; 22:1021-1027.
13. DeGroot LJ, Pacini F. Thyroid neoplasia. In: DeGroot LJ, Hennemann G (editors): Thyroid Disease Manager.
14. Morris LF, Waxman AD, Braunstein GD. Thyroid stunning. Thyroid 2003; 13:333-340.
15. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598-605.
16. 131I in the treatment of patients with differentiated thyroid cancer? Nucl Med Commun 1996; 17:199-207.
17. Leung SF, Law MW, Ho SK. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases. Br J Radiol 1992; 65:905-909.
18. DeGroot LJ, Reilly M. Comparison of 30 and 50舁mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 1992; 96:51-53.
19. Rosario PW, Maia FF, Cardoso LD, Barroso A, Rezende L, Padrao EL, Purisch S. Correlation between cervical uptake and results of postsurgical radioiodine ablation in patients with thyroid carcinoma. Clin Nucl Med 2004; 29:358-361.
20. Rosario PW, Cardoso LD, Barroso AL, Rezende LL, Padrao EL, Purisch S. Repercussions of the persistence of large thyroid remnants after bilateral thyroidectomy on differentiated thyroid cancer. Arq Bras Endocrinol Metabol 2004; 48:379-383.
21. 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on postoperative cervical uptake. Nucl Med Commun 2004; 25:1077-1081.